Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Combination oncolytic herpes simplex virus and dendritic cell immunotherapy for the treatment of established murine neuroblastomas

Combination oncolytic herpes simplex virus and dendritic cell immunotherapy for the treatment of established murine neuroblastomas. The New England Neurosurgical Society. 2007.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.